The global local anesthesia drugs market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing number of surgeries and rising demand for minimally invasive procedures, which require less pain management.
The global local anesthesia drugs market is segmented on the basis of type, application and region. On the basis of type, it is classified into articaine, bupivacaine, lidocaine, mepivacaine and prilocaine. On the basis of application it includes stomatology (dental), ophthalmology (eye) and gynecology (female reproductive system). On the basis of region it includes North America (US & Canada), Latin America (Mexico & Brazil), Europe (Germany & France), Asia Pacific excluding Japan (APeJ) and Middle East & Africa(MEA).
Some Of The Growth Factors Of This Market:
- The global population is increasing and aging, which will lead to an increase in the number of people with chronic pain.
- The global population is becoming more urbanized, which will lead to an increase in the number of people living in high-rise buildings who are at risk for falls and fractures.
- There has been a shift from hospital-based care to home-based care, which will lead to an increase in the number of patients who need postoperative pain relief after surgery or other procedures performed outside of a hospital setting.
- There has been a shift from invasive surgical procedures to less invasive surgical procedures, such as laparoscopic surgery, which will lead to an increased demand for postoperative pain relief after these types of surgeries or other procedures performed outside of a hospital setting.
- Advances in medical technology have led to new treatments for chronic diseases that cause severe pain.
Industry Growth Insights published a new data on “Local Anesthesia Drugs Market”. The research report is titled “Local Anesthesia Drugs Market research by Types (Articaine, Bupivacaine, Lidocaine, Mepivacaine, Prilocaine), By Applications (Stomatology, Ophthalmology, Gynecology, Other), By Players/Companies Mylan, Novartis, Fresenius Kabi, Aspen Pharmacare, Sagent Pharmaceutical, Pacira Pharmaceutical, Teva Pharmaceuticals, Pierrel group”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Local Anesthesia Drugs Market Research Report
By Type
Articaine, Bupivacaine, Lidocaine, Mepivacaine, Prilocaine
By Application
Stomatology, Ophthalmology, Gynecology, Other
By Companies
Mylan, Novartis, Fresenius Kabi, Aspen Pharmacare, Sagent Pharmaceutical, Pacira Pharmaceutical, Teva Pharmaceuticals, Pierrel group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Local Anesthesia Drugs Market Report Segments:
The global Local Anesthesia Drugs market is segmented on the basis of:
Types
Articaine, Bupivacaine, Lidocaine, Mepivacaine, Prilocaine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Stomatology, Ophthalmology, Gynecology, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Novartis
- Fresenius Kabi
- Aspen Pharmacare
- Sagent Pharmaceutical
- Pacira Pharmaceutical
- Teva Pharmaceuticals
- Pierrel group
Highlights of The Local Anesthesia Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Articaine
- Bupivacaine
- Lidocaine
- Mepivacaine
- Prilocaine
- By Application:
- Stomatology
- Ophthalmology
- Gynecology
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Local Anesthesia Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Local anesthetics are drugs that block nerve impulses and cause anesthesia. They are used to treat pain, inflammation, and other medical conditions.
Some of the key players operating in the local anesthesia drugs market are Mylan, Novartis, Fresenius Kabi, Aspen Pharmacare, Sagent Pharmaceutical, Pacira Pharmaceutical, Teva Pharmaceuticals, Pierrel group.
The local anesthesia drugs market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Local Anesthesia Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Local Anesthesia Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Local Anesthesia Drugs Market - Supply Chain
4.5. Global Local Anesthesia Drugs Market Forecast
4.5.1. Local Anesthesia Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Local Anesthesia Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Local Anesthesia Drugs Market Absolute $ Opportunity
5. Global Local Anesthesia Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Local Anesthesia Drugs Market Size and Volume Forecast by Type
5.3.1. Articaine
5.3.2. Bupivacaine
5.3.3. Lidocaine
5.3.4. Mepivacaine
5.3.5. Prilocaine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Local Anesthesia Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Local Anesthesia Drugs Market Size and Volume Forecast by Application
6.3.1. Stomatology
6.3.2. Ophthalmology
6.3.3. Gynecology
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Local Anesthesia Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Local Anesthesia Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Local Anesthesia Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Local Anesthesia Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Local Anesthesia Drugs Demand Share Forecast, 2019-2026
9. North America Local Anesthesia Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Local Anesthesia Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Local Anesthesia Drugs Market Size and Volume Forecast by Application
9.4.1. Stomatology
9.4.2. Ophthalmology
9.4.3. Gynecology
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Local Anesthesia Drugs Market Size and Volume Forecast by Type
9.7.1. Articaine
9.7.2. Bupivacaine
9.7.3. Lidocaine
9.7.4. Mepivacaine
9.7.5. Prilocaine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Local Anesthesia Drugs Demand Share Forecast, 2019-2026
10. Latin America Local Anesthesia Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Local Anesthesia Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Local Anesthesia Drugs Market Size and Volume Forecast by Application
10.4.1. Stomatology
10.4.2. Ophthalmology
10.4.3. Gynecology
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Local Anesthesia Drugs Market Size and Volume Forecast by Type
10.7.1. Articaine
10.7.2. Bupivacaine
10.7.3. Lidocaine
10.7.4. Mepivacaine
10.7.5. Prilocaine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Local Anesthesia Drugs Demand Share Forecast, 2019-2026
11. Europe Local Anesthesia Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Local Anesthesia Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Local Anesthesia Drugs Market Size and Volume Forecast by Application
11.4.1. Stomatology
11.4.2. Ophthalmology
11.4.3. Gynecology
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Local Anesthesia Drugs Market Size and Volume Forecast by Type
11.7.1. Articaine
11.7.2. Bupivacaine
11.7.3. Lidocaine
11.7.4. Mepivacaine
11.7.5. Prilocaine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Local Anesthesia Drugs Demand Share, 2019-2026
12. Asia Pacific Local Anesthesia Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Local Anesthesia Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Local Anesthesia Drugs Market Size and Volume Forecast by Application
12.4.1. Stomatology
12.4.2. Ophthalmology
12.4.3. Gynecology
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Local Anesthesia Drugs Market Size and Volume Forecast by Type
12.7.1. Articaine
12.7.2. Bupivacaine
12.7.3. Lidocaine
12.7.4. Mepivacaine
12.7.5. Prilocaine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Local Anesthesia Drugs Demand Share, 2019-2026
13. Middle East & Africa Local Anesthesia Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Local Anesthesia Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Local Anesthesia Drugs Market Size and Volume Forecast by Application
13.4.1. Stomatology
13.4.2. Ophthalmology
13.4.3. Gynecology
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Local Anesthesia Drugs Market Size and Volume Forecast by Type
13.7.1. Articaine
13.7.2. Bupivacaine
13.7.3. Lidocaine
13.7.4. Mepivacaine
13.7.5. Prilocaine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Local Anesthesia Drugs Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Local Anesthesia Drugs Market: Market Share Analysis
14.2. Local Anesthesia Drugs Distributors and Customers
14.3. Local Anesthesia Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Mylan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fresenius Kabi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Aspen Pharmacare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sagent Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Pacira Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pierrel group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
